Biological Products, (No Diagnostic Substances) companies: boards of directors (SIC 2836)
- Organizations
- 154
- Directors
- 1,361
- Average board size
- 9.8
| Organization | Directors | CEO |
|---|---|---|
| Autolus Therapeutics plc American Depositary Share Nasdaq: AUTL · London, United Kingdom | 22 | Christian Itin |
| Immunocore Holdings plc Nasdaq: IMCR · Oxfordshire, United Kingdom | 19 | Bahija Jallal |
| LENZ Therapeutics Inc. Nasdaq: LENZ · Solana Beach, United States | 19 | Evert B. Schimmelpennink |
| Kalaris Therapeutics Inc. Nasdaq: KLRS · Berkeley Heights, United States | 17 | Diana Brainard |
| Vor Biopharma Inc. Nasdaq: VOR · Boston, United States | 17 | Jean-Paul Kress |
| Humacyte Inc. Nasdaq: HUMA · Durham, United States | 16 | Laura E. Niklason |
| Maze Therapeutics Inc. Nasdaq: MAZE · South SAN Francisco, United States | 16 | Jason Coloma V |
| Amgen Inc. Nasdaq: AMGN · Thousand Oaks, United States | 15 | Robert A. Bradway |
| Fate Therapeutics Inc. Nasdaq: FATE · SAN Diego, United States | 15 | J. Scott Wolchko |
| Replimune Group Inc. Nasdaq: REPL · Woburn, United States | 15 | Philip Astley-Sparke |
| SAB Biotherapeutics Inc. Nasdaq: SABS · Miami Beach, United States | 15 | Eddie Joe Sullivan |
| Tectonic Therapeutic Inc. Nasdaq: TECX · Watertown, United States | 15 | Alise Reicin |
| Vir Biotechnology Inc. Nasdaq: VIR · SAN Francisco, United States | 15 | George A. Scangos |
| Atara Biotherapeutics Inc. Nasdaq: ATRA · Thousand Oaks, United States | 14 | Pascal Touchon |
| BioCryst Pharmaceuticals Inc. Nasdaq: BCRX · Durham, United States | 14 | Jon P. Stonehouse |
| Denali Therapeutics Inc. Nasdaq: DNLI · South SAN Francisco, United States | 14 | Ryan J. Watts |
| Exelixis Inc. Nasdaq: EXEL · Alameda, United States | 14 | Michael Morrissey |
| Invivyd Inc. Nasdaq: IVVD · New Haven, United States | 14 | David Hering |
| ImageneBio Inc. Nasdaq: IMA · SAN Diego, United States | 13 | Kristin Yarema |
| Jasper Therapeutics Inc. Nasdaq: JSPR · Redwood City, United States | 13 | Ron Martell |
| Kymera Therapeutics Inc. Nasdaq: KYMR · Watertown, United States | 13 | Nello Mainolfi |
| Quince Therapeutics Inc. Nasdaq: QNCX · South SAN Francisco, United States | 13 | Dirk Thye |
| Solid Biosciences Inc. Nasdaq: SLDB · Charlestown, United States | 13 | Alexander Cumbo |
| Vaxcyte Inc. Nasdaq: PCVX · SAN Carlos, United States | 13 | Grant Pickering |
| Zura Bio Limited Nasdaq: ZURA · La Jolla, Cayman Islands | 13 | Someit Sidhu |
| Artiva Biotherapeutics Inc. Nasdaq: ARTV · SAN Diego, United States | 12 | Fred Aslan |
| Bio-Techne Corp Nasdaq: TECH · Minneapolis, United States | 12 | Charles R. Kummeth |
| Biogen Inc. Nasdaq: BIIB · Cambridge, United States | 12 | Christopher Viehbacher |
| Black Diamond Therapeutics Inc. Nasdaq: BDTX · Cambridge, United States | 12 | Mark A. Velleca |
| C4 Therapeutics Inc. Nasdaq: CCCC · Watertown, United States | 12 | Andrew Hirsch |
| Calidi Biotherapeutics Inc. NYSE American: CLDI · SAN Diego, United States | 12 | Eric E. Poma |
| Candel Therapeutics Inc. Nasdaq: CADL · Needham, United States | 12 | Paul Peter Tak |
| Ginkgo Bioworks Holdings Inc. NYSE: DNA · Boston, United States | 12 | — |
| Halozyme Therapeutics Inc. Nasdaq: HALO · SAN Diego, United States | 12 | Helen Torley |
| Inhibikase Therapeutics Inc. Nasdaq: IKT · Wilmington, United States | 12 | Mark T. Iwicki |
| Kyverna Therapeutics Inc. Nasdaq: KYTX · Emeryville, United States | 12 | Warner Weston Biddle |
| Moderna Inc. Nasdaq: MRNA · Cambridge, United States | 12 | Stephane Bancel |
| Outlook Therapeutics Inc. Nasdaq: OTLK · Iselin, United States | 12 | C. Russell Trenary III |
| Palisade Bio Inc. Nasdaq: PALI · Carlsbad, United States | 12 | John David Finley |
| Recursion Pharmaceuticals Inc. Nasdaq: RXRX · Salt Lake City, United States | 12 | Christopher Gibson |
| Alector Inc. Nasdaq: ALEC · South SAN Francisco, United States | 11 | Arnon Rosenthal |
| Century Therapeutics Inc. Nasdaq: IPSC · Philadelphia, United States | 11 | Brent Pfeiffenberger |
| Coherus Oncology Inc. Nasdaq: CHRS · Redwood City, United States | 11 | Dennis M. Lanfear |
| CRISPR Therapeutics AG Nasdaq: CRSP · ZUG, Switzerland | 11 | Samarth Kulkarni |
| enGene Therapeutics Inc. Nasdaq: ENGN · Saint-Laurent, Canada | 11 | Ronald Harold Wilfred Cooper |
| LeonaBio Inc. Nasdaq: LONA · Bothell, United States | 11 | Mark James Litton |
| Neurocrine Biosciences Inc. Nasdaq: NBIX · SAN Diego, United States | 11 | Kevin Charles Gorman |
| Odyssey Therapeutics Inc. Nasdaq: ODTX · Boston, United States | 11 | — |
| REGENXBIO Inc. Nasdaq: RGNX · Rockville, United States | 11 | Kenneth T. Mills |
| Relay Therapeutics Inc. Nasdaq: RLAY · Cambridge, United States | 11 | Sanjiv Patel |
Organizations whose headquarters, sector or industry code is on file and that have at least one current director. Sectors not on file are derived from the industry code (an approximate match to GICS). Board sizes count every current seat on record; see where our data comes from.